Crinetics Pharmaceuticals annual gross margin
2023
2024
2025
Crinetics Pharmaceuticals Gross Margin Growth & History (CRNX)
Crinetics Pharmaceuticals's gross margin was 86.02% for fiscal 2025.
View full Crinetics Pharmaceuticals company overviewCrinetics Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 86.02% | −13.98 pp |
| 2024 | 2024-12-31 | 100.00% | 0.00 pp |
| 2023 | 2023-12-31 | 100.00% | — |
Crinetics Pharmaceuticals quarterly gross margin
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 99.39% | −0.61 pp |
| Q1 2026 | 2026-03-31 | 98.14% | −1.86 pp |
| Q2 2025 | 2025-06-30 | 100.00% | — |
| Q1 2025 | 2025-03-31 | 100.00% | — |
Crinetics Pharmaceuticals gross margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Crinetics Pharmaceuticals's gross margin decreased from 100.00% to 86.02%, a change of −13.98 percentage points. The latest reported quarter, Q2 2026, shows 99.39%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crinetics Pharmaceuticals source filings ↗